aTYR PHARMA (ATYR) Shares Outstanding (Entity) (2014 - 2026)
Powered by 
Analysis
aTYR PHARMA (ATYR) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 399.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 722.67 Mn |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - | 98.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.09 Mn |
| Mar 31, 2026 | 98.05 Mn |
| Dec 31, 2025 | 98.03 Mn |
| Sep 30, 2025 | 97.99 Mn |
| Jun 30, 2025 | 92.87 Mn |
| Mar 31, 2025 | 89.00 Mn |
| Dec 31, 2024 | 84.04 Mn |
| Sep 30, 2024 | 75.81 Mn |
| Jun 30, 2024 | 75.80 Mn |
| Mar 31, 2024 | 68.35 Mn |
| Dec 31, 2023 | 63.29 Mn |
| Sep 30, 2023 | 58.56 Mn |
| Jun 30, 2023 | 57.05 Mn |
| Mar 31, 2023 | 41.90 Mn |
| Dec 31, 2022 | 29.50 Mn |
| Sep 30, 2022 | 29.01 Mn |
| Jun 30, 2022 | 28.13 Mn |
| Mar 31, 2022 | 28.06 Mn |
| Dec 31, 2021 | 19.08 Mn |
| Sep 30, 2021 | 18.16 Mn |